Evidence map›Paper›PMID 27833852›Full record

ArticleFEBS open bio2016

Molecular cloning, heterologous expression, and enzymatic characterization of lysoplasmalogen-specific phospholipase D from

Yusaku Matsumoto, Nana Kashiwabara, Takayuki Oyama, Kazutaka Murayama, Hideyuki Matsumoto, Shin-Ich Sakasegawa, Daisuke Sugimori

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FEBS open bio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Corrigendum.FEBS open bio · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yusaku MatsumotoDepartment of Symbiotic Systems Science and Technology Graduate School of Symbiotic Systems Science and Technology Fukushima University Japan.
Nana KashiwabaraDepartment of Symbiotic Systems Science and Technology Graduate School of Symbiotic Systems Science and Technology Fukushima University Japan.
Takayuki OyamaDepartment of Symbiotic Systems Science and Technology Graduate School of Symbiotic Systems Science and Technology Fukushima University Japan.
Kazutaka MurayamaDivision of Biomedical Measurements and Diagnostics Graduate School of Biomedical Engineering Tohoku University Sendai Japan.
Hideyuki MatsumotoAsahi Kasei Pharma Corp. Izunokuni Shizuoka Japan.
Shin-Ich SakasegawaAsahi Kasei Pharma Corp. Izunokuni Shizuoka Japan.
Daisuke SugimoriDepartment of Symbiotic Systems Science and Technology Graduate School of Symbiotic Systems Science and Technology Fukushima University Japan.
Fukushima University · JPAsahi Kasei (Japan) · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysoplasmalogen (LyPls)-specific phospholipase D (LyPls-PLD) is an enzyme that catalyses the hydrolytic cleavage of the phosphoester bond of LyPls, releasing ethanolamine or choline, and 1-(1-alkenyl)- DATA ACCESSIBILITY: ENZYME: EC number EC 3.1.4.4.

Indexed as

biochemical characterizationcloning and heterologous expressionhead group recognitionlysoplasmalogen‐specific phospholipase DThermocrispum sp.

Identifiers

PMID27833852
PMCPMC5095149
OpenAlexW2527381215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.